The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs
Open accessAbstract
BACKGROUND: People who take analgesic drugs frequently may be at increased risk of end-stage renal disease (ESRD), but the extent of this risk remains unclear. METHODS: We studied 716 patients treated for ESRD and 361 control subjects of similar age from Maryland, Virginia, West Virginia, and Washington, D.C. The study participants were interviewed by telephone about their past use of medications containing acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (NSAIDs). For each analgesic drug, the average use (in pills per year) and the cumulative intake (in pills) were examined for any association with ESRD. RESULTS: Heavier acetaminophen use was associated with an increased risk of ESRD in a dose-dependent fashion. When persons who took an average of 0 to 104 pills per year were used for reference, the odds ratio of ESRD was 1.4 (95 percent confidence interval, 0.8 to 2.4) for those who took 105 to 365 pills per year and 2.1 (95 percent confidence interval, 1.1 to 3.7) for those who took 366 or more pills per year, after adjustment for race, sex, age, and intake of other analgesic drugs. When persons who had taken fewer than 1000 pills containing acetaminophen in their lifetime were used for reference, the odds ratio was 2.0 (95 percent confidence interval, 1.3 to 3.2) for those who had taken 1000 to 4999 pills and 2.4 (95 percent confidence interval, 1.2 to 4.8) for those who had taken 5000 or more pills. Approximately 8 to 10 percent of the overall incidence of ESRD was attributable to acetaminophen use. A cumulative dose of 5000 or more pills containing NSAIDs was also associated with an increased odds of ESRD (odds ratio, 8.8), but the use of aspirin was not. CONCLUSIONS: People who often take acetaminophen or NSAIDs have an increased risk of ESRD, but not those who often take aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Renal damage is also produced by chronic use of paracetamol; in a case-control study involving 1,077 subjects who frequently took paracetamol, a dose-dependent relationship between heavier paracetamol use and an increased risk of end-stage renal disease was demonstrated (160).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [160]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B. D., & Lemeshow, S. A. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,175
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 977
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Analgesic Use and Chronic Renal Disease
Sandler, D. P., Smith, J. C., Weinberg, C. R., Buckalew, V. M., Dennis, V. W., Blythe, W. B., & Burgess, W. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201903 · Cited by 254
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213
Renal Effects of Ibuprofen, Piroxicam, and Sulindac in Patients with Asymptomatic Renal Failure
Whelton, A., Stout, R. L., Spilman, P. S., & Klassen, D. K. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-568 · Cited by 203
An Epidemiologic Study of Abuse of Analgesic Drugs
Dubach, U. C., ROSNER, B. A., & Stürmer, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240304 · Cited by 123
Regular Analgesic Intake and the Risk of End-Stage Renal Failure
Pommer, W., Bronder, E., Greiser, E. M., Helmert, U., dagger, H. J. J., Klimpel, A., Borner, K., & Molzahn, M. (2008) · American Journal of Nephrology · doi:10.1159/000168002 · Cited by 111
Research works printed but not linked: 1
- Spuhler O, 1953, Z Klin Med, 151, 1
Cited by
Sorted by citations
Items 301–400 of 481
Voicu, V. A., Mircioiu, I., Sandulovici, R. C., Mircioiu, C., Pleşa, C., Velescu, B. Ș., & Anuța, V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00758 · Cited by 7
“, 1996), kidney failiure (Perneger et al., 1994), or acetaminophen-induced hypotension (Brown, 1996).”
BackgroundDavazdahemami, B., & Delen, D. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.02.010 · Cited by 7
Ide, K., Fujiwara, T., Shimada, N., & Tokumasu, H. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02596-7 · Cited by 7
Common Analgesic Agents and Their Roles in Analgesic Nephropathy: A Commentary on the Evidence
Yaxley, J. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.6.310 · Cited by 7
FACILITY LOCATION OF ORGAN PROCUREMENT ORGANISATIONS IN INDIAN HEALTH CARE SUPPLY CHAIN MANAGEMENT
Rajmohan, M., Theophilus, C., Sumalatha, M. R., & Saravanakumar, S. (2017) · The South African Journal of Industrial Engineering · doi:10.7166/28-1-1508 · Cited by 7
(2020) · Diabetes : current and future developments · doi:10.2174/97898114220031200101 · Cited by 7
Scientific basis for nucleoplasty
Singh, V. P. (2005) · Techniques in Regional Anesthesia and Pain Management · doi:10.1053/j.trap.2005.01.007 · Cited by 7
Management of mild-to-moderate osteoarthritis: Effective intervention by the nurse practitioner
Wright, W. L. (2008) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2007.09.014 · Cited by 7
McWilliam, L. J. (2007) · Current Diagnostic Pathology · doi:10.1016/j.cdip.2006.11.003 · Cited by 7
Lessons from chronic renal diseases in African Americans: treatment implications.
Agodoa, L. Y. C. (2003) · PubMed · Cited by 7
Adverse Drug Reactions Attributed to Ibuprofen
Miwa, L. J., Maneno, M. K., & Jones, J. K. (2015) · doi:10.1002/9781118743614.ch11 · Cited by 7
Uric Acid, Cardiovascular Mortality, and Long-Term Outcomes in CKD
Turgut, F. H., Kasapoğlu, B., & Kanbay, M. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.024 · Cited by 7
Clinical Consequences of Nonnarcotic Analgesic Use
Matzke, G. R. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100219 · Cited by 7
Working to Reform Marijuana Laws
Horgan, J., & Walsh, M. (2003) · Cited by 6
John, A., Amiri, L., Shafarin, J., Tariq, S., Adeghate, E. A., Howarth, F. C., & Raza, H. (2022) · Life · doi:10.3390/life12010104 · Cited by 6
“However, there are conflicting reports that NSAIDs cause nephrotoxicity, gastritis and bleeding [13,15,16].”
BackgroundPharmacology of COX-2 Inhibitors
Isakson, P. C. (2003) · KARGER eBooks · doi:10.1159/000071366 · Cited by 6
Sato, J., Morikawa, N., Nitanai, H., Nagashima, H., Nihei, S., Yamauti, K., & Kudo, K. (2016) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-016-0041-z · Cited by 6
“Combination use of nonsteroidal antiinflammatory drug (NSAIDs) was considered as the factor which influenced renal dysfunction [17, 18].”
BackgroundTaubert, M., Lückermann, M., Vente, A., Dalhoff, A., & Fuhr, U. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-17 · Cited by 6
Nonsteroidal Antiinflammatory Drugs and Opioids in Chronic Kidney Disease
Clive, D. M., & Clive, P. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00065-6 · Cited by 6
Yargıç, M. P., Torğutalp, Ş. Ş., & Erdağı, K. (2021) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.21.11604-4 · Cited by 6
Protective effect of Spathodea campanulata Bark against paracetamol-induced nephrotoxicity in rats.
Siddiq, A., Shanmukha, I., Rajendra, S., & Setty, S. R. (2012) · International Journal of PharmTech Research · Cited by 6
Paracetamol -- das sichere Analgetikum
Gleiter, C. H. (1997) · Der Internist · doi:10.1007/s001080050083 · Cited by 6
Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp
Göbel, H. (2012) · Springer eBooks · doi:10.1007/978-3-642-20695-5_8 · Cited by 6
Michon, M., Sellam, J., & Berenbaum, F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-9993-2.00023-0 · Cited by 6
Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: PRO
Barreto, E. F., & Feely, M. A. (2020) · Kidney360 · doi:10.34067/kid.0004582020 · Cited by 5
“Some studies have raised concerns about the potential for nephrotoxicity with acetaminophen as it is a metabolite of phenacetin, but these findings are inconsistent and of unclear clinical significance (13,14).”
BackgroundStegman, M. B. (2001) · Orthopaedic Nursing · doi:10.1097/00006416-200103000-00009 · Cited by 5
Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence
Yaxley, J. (2017) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-170735 · Cited by 5
Antiinflammatory Drugs and the Kidney
Weir, M. A., Ronco, C., & House, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00218-1 · Cited by 5
Halbritter, J., Mayer, C., Rasche, F., Amann, K., & Lindner, T. (2009) · Der Internist · doi:10.1007/s00108-009-2463-2 · Cited by 2
Risk factors affecting the incidence of chronic kidney disease
Turgut, F. H., Kanbay, M., Isik, B., & Akçay, A. (2007) · Kidney International · doi:10.1038/sj.ki.5002245 · Cited by 5
Saunthararajah, Y., & Vichinsky, E. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00042-1 · Cited by 6
Urinary biomarkers and nephrotoxicity
Finn, W. F., & Porter, G. A., Jr. (1998) · Springer eBooks · doi:10.1007/978-94-015-9088-4_35 · Cited by 5
Kidney Failure and Analgesic Drugs
Horowitz, R., Wilson, V. L., & Dart, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322213 · Cited by 5
Regmi, P., Aryal, N., Bhattarai, S., Sedhain, A., Radheshyam Krishna, K. C., & van Teijlingen, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309203 · Cited by 4
“There is an established link between analgesic drugs and kidney diseases [39, 40].”
BackgroundMadi, K., Yahiaoui, I., Arfi, R., Benkerrou, L., Khenniche, L., Lebik, H., Assadi, A. A., Khezami, L., Kriaa, K., & Benissad, F. (2025) · Water · doi:10.3390/w17111679 · Cited by 4
Inflammatory Abnormalities in Major Depressive Disorder
Singhal, G., & Baune, B. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00006-9 · Cited by 4
Sommer, A. H. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv157 · Cited by 4
Kelly, C., & Neilson, E. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10035-1 · Cited by 4
Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
Siddiqui, M. A., Jain, C., Usmani, A., Hafeez, A., Khalid, M., & Mujahid, M. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113026 · Cited by 5
Natural anti-inflammatory agents for the management of osteoarthritis
Rehman, S., Nabi, B., Baboota, S., & Ali, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816992-6.00004-8 · Cited by 4
Research Methods for Pharmacoepidemiology Studies
Salas, M., & Stricker, B. H. C. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8486-7_12 · Cited by 4
Direct‐to‐Consumer Advertising of OTC Agents Under Current FTC Regulations: Concerns and Comment
Sheftell, F. D., Dodick, D. W., & Cady, R. K. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041006534.x · Cited by 4
Pandemonium over painkillers persists
Cowan, D. T. (2007) · British Journal of Community Nursing · doi:10.12968/bjcn.2007.12.4.23253 · Cited by 4
Case Report: Analgesic Nephropathy: A Soda and a Powder
Appel, R. G., Bleyer, A. J., & McCabe, J. C. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199510000-00007 · Cited by 4
Workeneh, B., & Mitch, W. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00090-2 · Cited by 4
Göbel, H., Heinze, A., Dworschak, M., Heinze‐Kuhn, K., & Stolze, H. (2000) · Steinkopff eBooks · doi:10.1007/978-3-642-57735-2_12 · Cited by 4
Epidemiology of dialysis-treated end-stage kidney disease in adults in Libya
Alashek, W. A. (2013) · Nottingham ePrints (University of Nottingham) · Cited by 4
Gastrointestinal bleeding is common
Laporte, J., Vidal, X., & Carné, X. (1995) · BMJ · doi:10.1136/bmj.311.7001.391d · Cited by 4
Analgesic‐associated kidney disease
Thomas, M. C. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00625.x · Cited by 4
Hewitt, D., & Foley, K. M. (1997) · Springer eBooks · doi:10.1007/978-1-4757-2705-0_57 · Cited by 4
Shuwanto, H., Nguyen, T.-B., Chen, C.-W., & Dong, C. (2026) · Environmental Research · doi:10.1016/j.envres.2026.123675 · Cited by 3
Monné, S. B., Urgell, C. V., Pérez‐Sáez, M. J., Cunillera, O., Baena-Díez, J. M., Pascual, J., Lago, C., Ruiz, J. R., Salvador-González, B., & Morros, R. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00771-5 · Cited by 3
Kim, Y.-E., Park, S. Y., Lee, J. S., Ha, Y., Yoo, S., Kim, S., Ahn, S. M., Hong, S.-C., Lee, C., Yoo, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07146-8 · Cited by 3
Aspirin: Antiinflammatory Drug of Choice in 2011?
Tiliakos, A. M., & Conn, D. L. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100801 · Cited by 3
Twenty-Three-Year Trends in the Use of Potentially Nephrotoxic Drugs in Denmark
Enevoldsen, F. C., Christiansen, C. F., & Jensen, S. K. (2023) · Clinical Epidemiology · doi:10.2147/clep.s397415 · Cited by 3
Basic Principles in Osteoarthritis Treatment
Choquette, D., Raynauld, J., & Rich, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-60026-5_18 · Cited by 3
Aspirin and Nonsteroidal Agents
Seger, D., & Murray, L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00147-x · Cited by 3
COVID-19: Current Challenges and Future Perspectives
Leggat, P., Frean, J., & Blumberg, L. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3119-9 · Cited by 4
Pain and Chronic Kidney Disease
Cohen, S. D., Davison, S. N., & Kimmel, P. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00078-4 · Cited by 3
Research Methods for Pharmacoepidemiology Studies
Salas, M., & Stricker, B. H. C. (2014) · Springer eBooks · doi:10.1007/978-3-319-05470-4_12 · Cited by 3
Dischinger, H. R., Cheng, E. C., Mann, A. D., Grueber, T. M., Hawk, S., Davis, L. A., Prochazka, A. V., Hutt, E., & Caplan, L. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12351 · Cited by 3
Klinisch relevante Faktoren der Progressionshemmung
Reichel, H. (2012) · Der Nephrologe · doi:10.1007/s11560-011-0590-y · Cited by 3
Lee, S., Kim, J.-H., Cho, W.-S., Seo, S.-W., Kim, S., & Oh, J.-H. (2005) · Preventive Nutrition and Food Science · doi:10.3746/jfn.2005.10.3.285 · Cited by 3
Outcome of subjects with elevated serum creatinine in a community-based mass screening
Iseki, K., Ikemiya, Y., & Fukiyama, K. (1998) · Clinical and Experimental Nephrology · doi:10.1007/bf02480621 · Cited by 3
Efeitos renais adversos dos anti-inflamatórios não hormonais: uma abordagem prática.
Vaz, V. D., Delfino, A., & Mocelin, A. J. (1995) · Cited by 3
Which NSAID for your patient with osteoarthritis?
Scheiman, J. M., & Sidote, D. (2010) · PubMed · Cited by 3
Chronic tubulointerstitial nephritis
Broe, M. E. D., Jayasumana, C., D’Haese, P. C., Elseviers, M. M., & Vervaet, B. A. (2020) · doi:10.1093/med/9780198746690.003.0490 · Cited by 3
Coping with college stress: Does sense of coherence influence the use of alcohol and OTC medication?
Silver, R. A. (2013) · Syracuse University Libraries (Syracuse University) · Cited by 3
Nonopioid Analgesics, Salicylates, NSAIDs, and Corticosteroids for Chronic Pain
Dionne, R. A., & Clark, G. T. (2012) · doi:10.1002/9781118704851.ch3 · Cited by 3
Huang, X., Liu, Z., Quan, Z., Guo, H.-Y., & Shen, Q. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106885 · Cited by 2
A REVIEW ON DRUG INDUCED NEPHROTOXICITY
Kumar, K. A. (2020) · doi:10.53555/jptcp.v27i3.3400 · Cited by 2
Chronic Interstitial Nephritis
Walker, R. G., Hewitson, T. D., & Becker, G. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8166-9_24 · Cited by 2
ARTHRITIS AND MUSCULOSKELETAL PAIN
Butler, M. J. (1997) · Anesthesiology Clinics of North America · doi:10.1016/s0889-8537(05)70334-5 · Cited by 2
Does regular use of non‐steroidal anti‐inflammatory drugs increase the risk of renal disease?
Kohlhagen, J., Katrib, A., Stafford, L., Brown, M. A., & Edmonds, J. P. (2002) · Nephrology · doi:10.1046/j.1440-1797.2002.00069.x · Cited by 2
Feasibility of using recipients of health promotional newsletters for post-marketing surveillance
Mead, L. A., Ford, D. E., ROHT, L. H., Beach, C., & Klag, M. J. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00195-x · Cited by 2
Self-citationTenidap: not just another NSAID?
Canvin, J., & Madhok, R. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.2.79 · Cited by 2
Pain and Chronic Kidney Disease
Cohen, S. D., & Davison, S. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00071-8 · Cited by 2
Manual Therapy, Acupuncture, and Chinese Herbal Medicine in the Geriatric Equine
Kenney, J. D., & McCormick, W. H. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160163-4/50011-6 · Cited by 2
Prescribing of Non-Steroidal Anti-Inflammatory Drugs to Patients with Diabetes Mellitus in Portugal
Vieira, M. B., Neves, J. S., Baptista, R. B., Leitão, L., Dias, C. V., Vicente, R., Nascimento, N., Leite, C. C., Rocha, I., & Magriço, R. (2019) · Acta Médica Portuguesa · doi:10.20344/amp.10815 · Cited by 2
End-Stage Renal Disease in the Gaza Strip and Its Relationship to Risk Factors
Abu‐Odah, H., Abed, Y. A., El-Khateeb, A., Salah, M. S., & El-Nems, K. (2016) · Journal of US-China Medical Science · doi:10.17265/1548-6648/2016.01.004 · Cited by 2
Organic solvents, silicon-containing compounds and pesticides
D’Haese, P. C., Elseviers, M. M., Yaqoob, M. M., & Broe, M. E. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-84843-3_37 · Cited by 2
“Here, besides the development of the so-called analgesic nephropathy identifiable with high accuracy by the visualization of renal papillary necrosis [100], analgesic abuse also seems to accelerate the development and evolution of the other types of renal diseases [ 101 ].”
BackgroundEasing the burden of Alzheimer's disease: therapeutic options
Baumel, B. S. (1998) · European Journal of Neurology · doi:10.1111/j.1468-1331.1998.tb00445.x · Cited by 2
Elseviers, M. M., & Broe, M. E. D. (1998) · Springer eBooks · doi:10.1007/978-94-015-9088-4_13 · Cited by 2
Eicosanoids and Renal Function
Breyer, M. D., Harris, R. C., & BREYER, R. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00017-3 · Cited by 1
Pharmacotherapy of Pain in Older Adults: Nonopioid
McPherson, M. L., & Uritsky, T. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-618-4_7 · Cited by 1
Urinary enzimes excretion after acute administration of paracetamol in patients with kidney disease
Mitić-Zlatković, M., & Stefanović, V. (1998) · Cited by 1
Etiology, Diagnosis, and Management of Chronic Renal Insufficiency in the Aged
Rosenstock, J. L., & Michelis, M. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-72659-5_23 · Cited by 1
Role of Retama Raetam on Gentamicin-Induced Acute Kidney Injury in Experimental Rat Model
Menshawy, M. M., Farrag, A. R. H., Toumy, S. E., & Muhamed, G. (2021) · Egyptian Academic Journal of Biological Sciences. D, Histology and Histochemistry · doi:10.21608/eajbsd.2021.186478 · Cited by 1
“by long-term use of calcineurin inhibitors, lithium, some anticancer drugs, or analgesics (Perneger et al., 1994; Fored et al., 2001; Isnard Bagnis, et al., 2004; Rodriguez-Iturbe and Garcia Garcia, 2010).”
BackgroundDiagnosebezogene Therapieempfehlungen
Eckardt, A. (2011) · Springer eBooks · doi:10.1007/978-3-540-88507-8_6 · Cited by 1
Hackenthal, E. (1999) · Springer-Lehrbuch · doi:10.1007/978-3-642-98030-5_14 · Cited by 1
Anti-inflammatory Drugs and the Kidney
House, A. A., & Ronco, C. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4252-5.50317-8 · Cited by 1
Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease
Clive, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00057-3 · Cited by 1
Analgesic nephropathy as a cause of end-stage renal disease in a 55 year-old Nigerian
Okafor, U., Unuigbe, E., Onwuchekwa, A., & Emem-Chioma, P. (2012) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.97335 · Cited by 1
Induced Pluripotent Stem Cells and Vascular Disease
Kelaini, S., Cochrane, A., & Margariti, A. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-18314-5_5 · Cited by 1
Nonoperative Treatment of Knee Arthritis
Khanuja, H. S., Hungerford, M. W., Thompson, S. R., Goddard, M. S., & Mont, M. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1503-3.00092-5 · Cited by 1
Kasem, S., Hilal, M., Elsayed, R. M., MAHMOUD, S., & abdallah, A. (2019) · The Egyptian Journal of Forensic Sciences and Applied Toxicology · doi:10.21608/ejfsat.2019.7014.1044 · Cited by 1
The neuroprogressive nature of bipolar disorder: Mechanisms and implications
Singhal, G., & Baune, B. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00003-x · Cited by 1
ACETAMINOPHEN, ASPIRIN, AND CHRONIC RENAL FAILURE
Ichael, C. M., Ored, F., Jerblad, E. L. E., Indblad, P. E. L., Ryzek, P. F., Aul, P., Ickman, W. D., Isa, L., Ipworth, L. O. L., Lot, W. I. J. B., et al. (2001) · Cited by 1
Pharmacotherapy of Pain in Older Adults
McPherson, M. L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-668-3_7 · Cited by 1
Schrör, K. (2008) · Wiley eBooks · doi:10.1002/9783527625994.ch3 · Cited by 1
Metadata
- Authors
- Perneger, T. V., Whelton, P. K., & Klag, M. J.
- Affiliations
- University of Geneva (CH)
- Johns Hopkins University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-12-22
- Volume
- 331
- Issue
- 25
- Pages
- 1675-1679
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2320758398
- Cited by
- 484
- References
- 15
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 18 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 21 · 2019: 19 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 17 · 2014: 17 · 2013: 20 · 2012: 20
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (R03-HS06978-01)
- National Center for Research Resources (5MOIRR00722, RR 00035)
- Topics
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- end-stage renal disease, renal failure, paracetamol, aspirin, nonsteroidal anti-inflammatory drugs, analgesic use, dose-response relationship, attributable risk, drug-induced nephrotoxicity
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Drug Utilization, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Causality, Confidence Intervals, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review